BioCentury
ARTICLE | Company News

CuraGen, Roche deal

April 2, 2007 7:00 AM UTC

ROG will acquire CRGN’s 454 Life Sciences Corp. subsidiary for $140 million in cash. In addition, 454 shareholders may receive up to $14.9 million from the exercise of stock options in the private com...